Table 5.

Clinical and laboratory data in donors with a poor mobilization response to G-CSF

Post–G-CSF CD34+ cell count/μL	N	Sex, female/male, %	Ethnicity W/B/H/AP, %	G-CSF dose, μg/kg per day 10/16, %	Weight, kg	Height, cm	BMI, kg/m2	Estimated body fat, %	Age, y	Pre–G-CSF platelet count, ×109/L	Pre–G-CSF MNC, ×109/L	Total G-CSF, μg/d	Prior lymphapheresis, yes/no (%)
All donors	639	49/51	64/12/18/6	96/4	79	170	27.1	28.7	40.4	256	2.43	808	26/74
Less than 30	73	70/30	78/3/14/5	100/0	68	169	23.4	25.8	41.7	236	2.21	688	22/78
More than or equal to 30	566	48/52	64/13/19/6	95/5	80	171	27.5	29.1	40.3	259	2.46	822	26/74
P		<.001	.01	.1	<.001	.12	<.001	<.001	.3	.002	.002	<.001	.4
Less than 20	29	74/26	81/4/15/0	100/0	67	170	22.9	24.6	41.9	226	1.96	663	15/85
More than or equal to 20	610	49/51	64/12/18/6	95/5	79	170	27.1	28.9	40.4	260	2.45	812	26/74
P		.02	.08	.6	<.001	.4	<.001	<.001	.4	.006	<.001	<.001	.3